Howard S. Hochster, MD of Yale School of Medicine discusses the impact of molecular testing and screening on potential clinical trials at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
Impact of Molecular Testing on Upcoming Clinical Trials
